CPT® Code 87269

1. Indications

The test coded as CPT® 87269 is indicated for the detection of giardia antigen in patients who exhibit gastrointestinal symptoms. The following conditions or symptoms may warrant the use of this test:

• Diarrhea Persistent or acute diarrhea that may suggest a parasitic infection.
• Gastrointestinal Symptoms Symptoms such as abdominal pain, bloating, or cramping that are associated with giardiasis.
• Weight Loss Unexplained weight loss that may be linked to malabsorption due to giardia infection.
• Recent Exposure Situations where there is a potential exposure to contaminated food or water, particularly in symptomatic patients without a recent travel history.

2. Procedure

The procedure for conducting the giardia antigen detection test using CPT® 87269 involves several key steps:

• Sample Collection A fecal sample is collected from the patient, which serves as the specimen for testing. Proper collection techniques are essential to ensure the integrity of the sample.
• Slide Preparation The fecal sample is then applied to a microscope slide. This step is crucial as it prepares the sample for the subsequent immunofluorescent staining process.
• Reagent Application The slide is treated with a detection reagent that contains antibodies specific to giardia. This reagent binds to the giardia antigens present in the cysts, if they are present in the sample.
• Counterstaining A counterstain is applied to the slide to provide a contrasting background. This helps in visualizing the giardia cysts more clearly under the microscope.
• Microscopic Examination The slide is rinsed and examined under a fluorescent microscope equipped with a filter system for fluorescein isothiocyanate. The presence of giardia cysts will cause them to fluoresce a bright green color against the dull orange-red background created by the counterstain.
• Result Interpretation The test is reported as positive if one or more giardia cysts are detected in the sample, indicating a giardia infection.

3. Post-Procedure

After the completion of the giardia antigen detection test, the results are analyzed and reported. If the test is positive, it confirms the presence of giardia cysts in the fecal sample, indicating an active infection. Clinicians may then consider appropriate treatment options based on the patient's clinical presentation and the test results. It is important for healthcare providers to communicate the results to the patient and discuss any necessary follow-up care or additional testing that may be required. Patients may also be advised on preventive measures to avoid future infections, such as ensuring safe drinking water and practicing good hygiene.